搜索





搜索





Cue Biopharma Inc

CUE

添加自选

40.430USD

+2.590+6.84%

交易中 09/18, 09:42（美东）

211.42M总市值

亏损市盈率 TTM

Cue Biopharma Inc

40.430

+2.590+6.84%

财务摘要利润表资产负债表现金流量表财报公司估值风险评估

概览

新闻分析

财务

股票评分

技术分析

预测

持股情况

股息

公司资料

财务摘要利润表资产负债表现金流量表财报公司估值风险评估

CUE 利润表

您可以在这里找到Cue Biopharma Inc的年度或季度收入报告，以深入了解Cue Biopharma Inc的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

FY2016Q4

FY2016Q3

营业总收入

166.66%7.88M

1250.59%5.69M

1292.26%21.94M

-35.58%2.15M

11.14%2.95M

-75.48%421.00K

-13.45%1.58M

58.86%3.34M

92.33%2.66M

818.18%1.72M

1104.15%1.82M

2988.24%2.10M

5215.38%1.38M

-81.30%187.00K

-98.17%151.23K

-97.16%68.00K

-99.05%26.00K

-35.61%1.00M

1636.57%8.25M

240.20%2.40M

154.79%2.74M

72.56%1.55M

-54.70%475.32K

-28.46%704.00K

1.90%1.07M

143.24%900.00K

217.40%1.05M

119.15%984.00K

513.37%1.05M

--370.00K

--330.60K

--449.00K

--172.00K

--0.00

营业收入

166.66%7.88M

1250.59%5.69M

1292.26%21.94M

-35.58%2.15M

11.14%2.95M

-75.48%421.00K

-13.45%1.58M

58.86%3.34M

92.33%2.66M

818.18%1.72M

1104.15%1.82M

2988.24%2.10M

5215.38%1.38M

-81.30%187.00K

-98.17%151.23K

-97.16%68.00K

-99.05%26.00K

-35.61%1.00M

1636.57%8.25M

240.20%2.40M

154.79%2.74M

72.56%1.55M

-54.70%475.32K

-28.46%704.00K

1.90%1.07M

143.24%900.00K

217.40%1.05M

119.15%984.00K

513.37%1.05M

--370.00K

--330.60K

--449.00K

--172.00K

--0.00

营业费用

724.68%95.57M

-13.14%11.05M

78.35%19.98M

-20.86%9.69M

-11.13%11.59M

-11.57%12.72M

-27.69%11.21M

-9.40%12.25M

-12.47%13.04M

6.03%14.38M

3.06%15.50M

21.80%13.52M

11.40%14.90M

-10.97%13.57M

-6.89%15.04M

-27.99%11.10M

2.55%13.37M

8.29%15.24M

41.03%16.15M

42.25%15.41M

8.53%13.04M

1.27%14.07M

13.76%11.45M

34.13%10.84M

16.83%12.02M

17.78%13.89M

-10.91%10.06M

-38.84%8.08M

34.56%10.29M

56.83%11.80M

8.22%11.30M

162.48%13.21M

73.21%7.64M

124.54%7.52M

267.26%10.44M

148.59%5.03M

--4.41M

--3.35M

--2.84M

--2.02M

研发费用

519.23%48.98M

-20.11%6.83M

129.27%16.47M

-49.32%4.75M

-17.00%7.91M

-16.20%8.55M

-34.01%7.18M

-3.76%9.38M

-9.41%9.53M

10.59%10.20M

-3.93%10.89M

32.18%9.75M

12.14%10.52M

-5.92%9.22M

1.05%11.33M

-32.94%7.38M

10.72%9.38M

2.89%9.80M

44.30%11.21M

51.18%11.00M

7.62%8.47M

-1.45%9.53M

12.58%7.77M

43.73%7.27M

18.78%7.87M

18.53%9.67M

4.15%6.90M

-50.02%5.06M

26.75%6.63M

44.10%8.16M

-25.51%6.63M

160.83%10.13M

57.58%5.23M

136.13%5.66M

343.88%8.90M

188.75%3.88M

--3.32M

--2.40M

--2.00M

--1.34M

折旧摊销及损耗

-64.00%36.00K

460.40%566.00K

591.84%678.00K

-22.33%80.00K

-2.91%100.00K

2.02%101.00K

-13.27%98.00K

-21.37%103.00K

-24.26%103.00K

-44.07%99.00K

-44.40%113.00K

-34.83%131.00K

-36.74%136.00K

-41.58%177.00K

-34.37%203.24K

-36.39%201.00K

-31.53%215.00K

-4.72%303.00K

22.17%309.66K

17.47%316.00K

15.44%314.00K

20.91%318.00K

243.52%253.46K

1.89%269.00K

2.64%272.00K

26.44%263.00K

-64.01%73.78K

35.38%264.00K

35.90%265.00K

24.55%208.00K

62.02%205.01K

57.83%195.00K

90.27%195.00K

149.25%167.00K

102.31%126.53K

119.09%123.55K

--102.48K

--67.00K

--62.54K

--56.39K

营业利润

-915.58%-87.69M

56.39%-5.36M

120.33%1.96M

15.35%-7.54M

16.84%-8.63M

2.91%-12.30M

29.59%-9.63M

21.95%-8.91M

23.19%-10.38M

5.32%-12.67M

8.13%-13.68M

-3.52%-11.42M

-1.27%-13.52M

6.03%-13.38M

-88.58%-14.88M

15.26%-11.03M

-29.55%-13.35M

-13.74%-14.24M

28.08%-7.89M

-28.50%-13.02M

5.84%-10.30M

3.67%-12.52M

-21.73%-10.97M

-42.81%-10.13M

-18.54%-10.94M

-13.72%-12.99M

17.79%-9.02M

44.40%-7.09M

-23.54%-9.23M

-51.91%-11.43M

-5.06%-10.97M

-153.56%-12.76M

-69.32%-7.47M

-124.54%-7.52M

-267.26%-10.44M

-148.59%-5.03M

---4.41M

---3.35M

---2.84M

---2.02M

净非营业利息收入（费用）

利息收入

-20.71%157.00K

5.29%179.00K

-45.52%158.00K

-35.28%222.00K

-53.63%198.00K

-69.75%170.00K

-67.96%290.00K

-51.00%343.00K

-24.29%427.00K

-12.32%562.00K

43.14%905.00K

250.00%700.00K

540.91%564.00K

7912.50%641.00K

16119.65%632.24K

700.00%200.00K

266.67%88.00K

-38.46%8.00K

-0.41%3.90K

-79.67%25.00K

-82.09%24.00K

-93.60%13.00K

-96.43%3.91K

24.24%123.00K

39.58%134.00K

78.07%203.00K

5.48%109.71K

-2.94%99.00K

-43.53%96.00K

--114.00K

297065.71%104.01K

--102.00K

--170.00K

----

--35.00

-100.00%0.00

--0.00

----

--0.00

--32.00

利息费用

-88.89%5.00K

-96.88%4.00K

-66.67%51.00K

-60.11%75.00K

-79.07%45.00K

-46.89%128.00K

-69.82%153.00K

-34.27%188.00K

-7.33%215.00K

-34.86%241.00K

41.30%507.00K

130.65%286.00K

12.62%232.00K

1380.00%370.00K

--358.81K

--124.00K

--206.00K

--25.00K

----

特殊收入（费用）

--24.49M

--10.00K

----

-固定资产出售收益

----

600.00%20.00K

-152.58%-51.00K

----

97.45%-4.00K

--97.00K

--0.00

-100.00%0.00

-942.59%-157.00K

--0.00

-100.00%0.00

--2.00K

--18.63K

--0.00

--258.00K

----

其他非经营性收入（费用）

---90.01M

----

--0.00

100.00%0.00

--0.00

---2.00K

----

672.67%74.00K

-560.00%-23.00K

-196.15%-25.00K

-156.52%-26.00K

-119.48%-12.92K

-94.90%5.00K

1200.00%26.00K

4700.00%46.00K

--66.34K

--98.00K

--2.00K

---1.00K

----

--0.00

----

税前利润

-1704.61%-153.07M

57.75%-5.18M

121.96%2.08M

14.00%-7.45M

16.61%-8.48M

0.73%-12.26M

29.31%-9.50M

21.31%-8.66M

22.86%-10.17M

5.81%-12.35M

7.94%-13.43M

-0.46%-11.01M

0.17%-13.19M

8.04%-13.11M

-84.97%-14.59M

15.69%-10.96M

-28.49%-13.21M

-13.99%-14.26M

27.60%-7.89M

-29.53%-12.99M

5.11%-10.28M

2.44%-12.51M

-22.18%-10.90M

-43.51%-10.03M

-18.93%-10.83M

-13.77%-12.82M

17.39%-8.92M

44.34%-6.99M

-24.78%-9.11M

-49.77%-11.27M

-3.42%-10.80M

-149.59%-12.56M

-65.42%-7.30M

-124.57%-7.52M

-267.26%-10.44M

-148.60%-5.03M

---4.41M

---3.35M

---2.84M

---2.02M

所得税

----

--500.00K

----

-100.00%0.00

----

140.00%495.00K

----

41350.00%206.25K

----

-100.06%-500.00

--0.00

--413.00K

----

--825.00K

----

--0.00

----

--0.00

除税后利润

-1704.61%-153.07M

57.75%-5.18M

116.69%1.58M

14.00%-7.45M

16.61%-8.48M

0.73%-12.26M

29.31%-9.50M

21.31%-8.66M

22.86%-10.17M

5.81%-12.35M

7.94%-13.43M

-0.46%-11.01M

0.17%-13.19M

8.04%-13.11M

-74.05%-14.59M

15.69%-10.96M

-28.49%-13.21M

-13.99%-14.26M

24.49%-8.38M

-29.53%-12.99M

5.11%-10.28M

2.44%-12.51M

-24.50%-11.10M

-43.51%-10.03M

-13.77%-10.83M

-13.77%-12.82M

23.26%-8.92M

44.34%-6.99M

-30.44%-9.52M

-49.77%-11.27M

-11.33%-11.62M

-149.59%-12.56M

-65.42%-7.30M

-124.57%-7.52M

-267.26%-10.44M

-148.60%-5.03M

---4.41M

---3.35M

---2.84M

---2.02M

持续经营利润

-1704.61%-153.07M

57.75%-5.18M

116.69%1.58M

14.00%-7.45M

16.61%-8.48M

0.73%-12.26M

29.31%-9.50M

21.31%-8.66M

22.86%-10.17M

5.81%-12.35M

7.94%-13.43M

-0.46%-11.01M

0.17%-13.19M

8.04%-13.11M

-74.05%-14.59M

15.69%-10.96M

-28.49%-13.21M

-13.99%-14.26M

24.49%-8.38M

-29.53%-12.99M

5.11%-10.28M

2.44%-12.51M

-24.50%-11.10M

-43.51%-10.03M

-13.77%-10.83M

-13.77%-12.82M

23.26%-8.92M

44.34%-6.99M

-30.44%-9.52M

-49.77%-11.27M

-11.33%-11.62M

-149.59%-12.56M

-65.42%-7.30M

-124.57%-7.52M

-267.26%-10.44M

-148.60%-5.03M

---4.41M

---3.35M

---2.84M

---2.02M

归属于母公司的净利润

-1704.61%-153.07M

57.75%-5.18M

116.69%1.58M

14.00%-7.45M

16.61%-8.48M

0.73%-12.26M

29.31%-9.50M

21.31%-8.66M

22.86%-10.17M

5.81%-12.35M

7.94%-13.43M

-0.46%-11.01M

0.17%-13.19M

8.04%-13.11M

-74.05%-14.59M

15.69%-10.96M

-28.49%-13.21M

-13.99%-14.26M

24.49%-8.38M

-29.53%-12.99M

5.11%-10.28M

2.44%-12.51M

-24.50%-11.10M

-43.51%-10.03M

-13.77%-10.83M

-13.77%-12.82M

23.26%-8.92M

44.34%-6.99M

-30.44%-9.52M

-49.77%-11.27M

-11.33%-11.62M

-149.59%-12.56M

-65.42%-7.30M

-124.57%-7.52M

-267.26%-10.44M

-148.60%-5.03M

---4.41M

---3.35M

---2.84M

---2.02M

归属于普通股东的净利润

-1704.61%-153.07M

57.75%-5.18M

116.69%1.58M

14.00%-7.45M

16.61%-8.48M

0.73%-12.26M

29.31%-9.50M

21.31%-8.66M

22.86%-10.17M

5.81%-12.35M

7.94%-13.43M

-0.46%-11.01M

0.17%-13.19M

8.04%-13.11M

-74.05%-14.59M

15.69%-10.96M

-28.49%-13.21M

-13.99%-14.26M

24.49%-8.38M

-29.53%-12.99M

5.11%-10.28M

2.44%-12.51M

-24.50%-11.10M

-43.51%-10.03M

-13.77%-10.83M

-13.77%-12.82M

23.26%-8.92M

44.34%-6.99M

-30.44%-9.52M

-49.77%-11.27M

-11.33%-11.62M

-149.59%-12.56M

-65.42%-7.30M

-124.57%-7.52M

-267.26%-10.44M

-148.60%-5.03M

---4.41M

---3.35M

---2.84M

---2.02M

基本每股收益

-805.64%-24.14

-19474.79%-32.31

444.72%0.44

56.32%-0.07

56.17%-0.09

33.87%-0.17

55.18%-0.13

28.79%-0.17

31.13%-0.20

14.98%-0.25

23.57%-0.28

23.33%-0.24

21.21%-0.29

32.79%-0.29

-41.92%-0.37

24.90%-0.31

-13.51%-0.37

-6.30%-0.44

28.38%-0.26

-21.87%-0.41

14.27%-0.33

14.83%-0.41

0.71%-0.37

-8.65%-0.34

16.06%-0.38

11.29%-0.48

35.85%-0.37

50.09%-0.31

-26.11%-0.46

-45.04%-0.54

8.30%-0.58

-106.30%-0.62

-86.08%-0.36

-19.04%-0.37

-267.26%-0.63

-148.59%-0.30

---0.19

---0.31

---0.17

---0.12

稀释每股收益

-805.64%-24.14

-19474.79%-32.31

444.72%0.44

56.32%-0.07

56.17%-0.09

33.87%-0.17

55.18%-0.13

28.79%-0.17

31.13%-0.20

14.98%-0.25

23.57%-0.28

23.33%-0.24

21.21%-0.29

32.79%-0.29

-41.92%-0.37

24.90%-0.31

-13.51%-0.37

-6.30%-0.44

28.38%-0.26

-21.87%-0.41

14.27%-0.33

14.83%-0.41

0.71%-0.37

-8.65%-0.34

16.06%-0.38

11.29%-0.48

35.85%-0.37

50.09%-0.31

-26.11%-0.46

-45.04%-0.54

8.30%-0.58

-106.30%-0.62

-86.08%-0.36

-19.04%-0.37

-267.26%-0.63

-148.59%-0.30

---0.19

---0.31

---0.17

---0.12

每股派息

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 Cue Biopharma Inc 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 CUE 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

Cue Biopharma Inc 财年末的营收是多少？



Cue Biopharma Inc 2025 财年营收为 27.47M，高于上一财年的9.29M。

Cue Biopharma Inc 最近一个季度的营收是多少？



Cue Biopharma Inc 最近一个季度的营收为 7.88M，同比增长 166.66%。

Cue Biopharma Inc 全年的净利润是多少？



Cue Biopharma Inc 2025 财年净利润为 -26.60M。

Cue Biopharma Inc 上一季度的净利润是多少？



Cue Biopharma Inc 最近一个季度的净利润为 -153.07M。

Cue Biopharma Inc 年度营业利润是多少？



Cue Biopharma Inc 2025 财年的营业利润为 -26.52M。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。